The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 

How do changes in ownership impact patient care? That was one of the many topics explored in a new survey of U.S. physicians.

Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.

The deal could also include additional clinical and regulatory milestone payments in the years ahead.

The research will focus on ways to improve the utilization of electronic resources among heart failure patients and the doctors who treat them.

Avidity Biosciences, a San Diego-based biopharmaceutical company, is expanding its ongoing collaboration with Bristol Myers Squibb to identify new cardiovascular therapies.